Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alphyn, Antengene, Arcutis, Beckley Psytech, Daiichi Sankyo, Endevica, Enlivex, Excellthera, Innovent, Nanobiotix, Nouscom, Reistone, Vect-horus, Zyua.